Characterization of an MRP2 polymorphism, -24C>T, in the MRP2 5'UTR, demonstrated no effect on mRNA expression or downstream ORF translation. These data indicate for the first time that the 5'UTR of MRP2 mRNA transcripts and the uORF at -105 markedly influence MRP2 translation.
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INTRODUCTION
The multidrug resistance-associated protein 2 (MRP2; ABCC2) is an important transport protein mediating the efflux of organic anions across the apical domain of hepatocytes, enterocytes and renal proximal tubule cells. MRP2 mediates the ATPdependent efflux of glutathione, glucuronide and sulfate conjugates of endo-and xenobiotics, can mediate the efflux of chemotherapeutic drugs such as methotrexate, and is capable of GSH-stimulated transport of nonconjugated drugs, such as anthracyclines and Vinca alkaloids (Deeley et al., 2006) .
Investigation of MRP2 mRNA and protein expression in normal and cancerous kidney cortex found no difference in MRP2 mRNA expression between tumor tissue (clear-cell renal cell cancer; CCRCC) and tumor-free adjacent tissue, but MRP2 protein levels were significantly lower in CCRCC samples as compared to tumor-free adjacent tissue (Haenisch et al., 2007) . Further, duodenal MRP2 protein is markedly reduced in patients with inflammatory obstructive cholestasis, while MRP2 mRNA is unchanged (Geier et al., 2007) . These results indicate that under some conditions, the human MRP2 gene expression undergoes posttranscriptional regulation. We (Cao et al., 2001; Cao et al., 2002; Jones et al., 2005; Mottino et al., 2000) and others (Johnson et al., 2002; Johnson and Klaassen, 2002) have described posttranscriptional regulation of the homologous Mrp2 gene in the rat, and have further demonstrated its translational regulation (Zhang et al., 2007) .
Posttranscriptional regulation has been less comprehensively characterized compared to transcriptional regulation, although it is often known to be mediated by short sequence RNA elements located in the 5' or 3' untranslated regions (UTR) MOL 58982 (Pesole et al., 2001) . The regulation of translation by the 5'UTR is a major mechanism for posttranscriptional regulation of gene expression; one such element in the 5'UTR is the upstream open reading frame (uORF) .
uORFs can influence translation of downstream ORFs by regulating the selection or efficiency of the translation start site.
Translation of natural eukaryotic mRNA is predicted to initiate at the first ATG encountered by the scanning 40S ribosomal subunit, starting from the 5'm7G cap (Kozak, 1999) , and can thus inhibit translation of a downstream ORF. Translation of the downstream ORF by the ribosome occurs either through leaky scanning of uATGs in the 5'UTR when the sequence around the uATG is suboptimal (Kozak, 1986) , or through reinitiation when the translation machinery is not dissociated from the mRNA chain after termination of translation of an uORF (Morris and Geballe, 2000) . The uORF can also inhibit translation of a downstream ORF if translation of the encoded nascent peptide causes stalling of the ribosome, either at a termination codon, or during the elongation process (Hood et al., 2009 ). Alternatively, there may be internal ribosomal entry sites (IRES) located in the 5'UTR, such that the translation machinery skips the uATGs and instead, utilizes the IRES to initiate translation of the downstream ORF (Le and Maizel, 1997) . While some upstream start codons (uATGs) inhibit downstream ORF translation (Blaschke et al., 2003; Diba et al., 2001; Kwon et al., 2001; Meijer et al., 2000; Mihailovich et al., 2007; Song et al., 2007) , other uATGs have no such effect (Diba et al., 2001) . uORFs can also influence the stability of mRNA by a process termed nonsense-mediated mRNA decay (Hood et al., 2009) . In general, uORFs inhibit the translation of the downstream ORF (Morris and Geballe, 2000; Neafsey and Galagan, 2007; Zimmer et al., 2008) ; inhibition is dependent on the amino-MOL 58982 6 acid sequence of the uORF peptide in some genes (Luo and Sachs, 1996; Mize et al., 1998; Parola and Kobilka, 1994; Reynolds et al., 1996) but not in others (David-Assael et al., 2005 ).
While we have investigated the role of rat Mrp2 5'UTR and its uORFs in regulating translation of Mrp2 (Zhang et al., 2007) , and the human MRP2 is homologous to the rat Mrp2, the human MRP2 5'UTR appears more complicated, and its role in regulating expression of human MRP2 has not been investigated. Three transcription initiation sites at -247, -204 and -99 nucleotides relative to the start codon ATG of MRP2 have been determined by 5' RACE (Tanaka et al., 1999) . We here note the presence of seven upstream uATGs and six uORFs in the human MRP2 5'UTR, and demonstrate that uATGs in human MRP2 5'UTR inhibit translation efficiency of a downstream ORF, and that the uORF at -105 acts as a cis-inhibitor in the regulation of MRP2 translation.
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MATERIALS AND METHODS
Vector construction. The plasmid pGL3-control vector and Luciferase T7-control DNA vector were purchased from Promega (Madison, WI). MRP2 5'UTRs were amplified by PCR from cDNA that was reverse transcribed from mRNA isolated from HepG2 cells.
Gene specific primers were designed according to the published sequence information (Tanaka et al., 1999) and are shown in Table 1 . Figure 1 In vitro translation. For in vitro translation, the Rabbit Reticulocyte Lysate System (Promega, Madison, WI) was used according to the manufacturer's instructions. The DNA template T7-5'UTR-Luciferase cassette was amplified by PCR using two primers, T7F and LucR, using individual plasmid DNA as template. The PCR product was separated on 0.7% agarose gel and purified using a Qiagen Gel purification column and quantified by UV spectrophotometry. For mRNA synthesis, the mMESSAGE mMACHINE kit from Ambion (Austin, TX) was used according to the manufacturer's instructions. The mRNA was purified and quantified by UV spectrophotometry.
Alternatively, mRNA was also labeled with α- (Table 1) were used with UPL probe #29.
For detection of 18s RNA, Primers 18sF and 18sR were used with UPL probe #81. In detail, 1 µg of total RNA was used for cDNA synthesis and then the synthesized cDNA was diluted to 500 µl. Diluted cDNA (5 µl) was used as template in a 20 µl reaction volume. The target gene expression was normalized by its 18s RNA gene expression.
Data analysis. Statistical differences were assessed using one-way analysis of variance (ANOVA). Post hoc comparisons were performed using Statview software.
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RESULTS
Sequence analysis of cDNA shows that the 5'UTR of MRP2 contains seven start codon relative to the MRP2 start codon ATG; however, the ATG at -180 is followed immediately by a stop codon (TAA), so that there are only 6 uORF (Fig 1) . The uATG at -105 is flanked by a perfect Kozak motif (AGAATGGTA), is in-frame with the MRP2 ORF, terminates at TAA-39, is followed by a second stop codon (TAG) and is predicted to encode a 22 amino acid peptide. There is also an out-of-frame uATG at -74 in the middle of this uORF and the coding sequence of this uORF extends past the start codon for MRP2 to +234 (Fig.1) .
Interestingly, the MRP2 ATG (ATCATGC) lacks a perfect Kozak motif. Several transcription initiation sites were detected in the MRP2 5'UTR using RPA in liver, placenta, kidney, small intestine and HepG2 cells (Fig. 1) .These data confirmed the previously reported three transcription initiation sites at -247, -204 and -99 (Tanaka et al., 1999) and also showed additional transcription initiation sites in HepG2 cells, liver, kidney and small intestine. MRP2 mRNA transcripts in liver and HepG2 cell are essentially identical, but differed from those in placenta, kidney and small intestines.
The major bands in HepG2 cells and liver were detected at -204, around -150, -120, -99
and -70, and a relatively weak band at -247. In placenta, the major band was detected at -247, while the kidney showed major bands around -150, -120, -99 and -70 and relatively weak bands at -247 and -204. The small intestine showed major bands around -99 and -70, relatively weak bands around -247 and -150, and no detectable band at -204 ( Fig.1 ).
This article has not been copyedited and formatted. The final version may differ from this version. Human MRP2 5'UTRs were obtained by RT-PCR and successfully cloned into the pGL3 control and Luciferase T7 control DNA vectors (Fig. 2a, 3a) . To investigate the regulatory role of the MRP2 5'UTR on downstream ORF expression, we inserted MRP2 5'UTRs and the uORF-disrupted mutants between the SV40 promoter and the luciferase gene for HepG2 cell transfection studies, (Fig.2a) . In SV40-5'UTR-Luciferase cassette-transfected HepG2 cells, the -99 construct showed a significantly higher luciferase activity compared to the -247, -204 or C35 control constructs (Fig. 2b) , despite the absence of any significant differences in the luciferase mRNA expression among these constructs (Fig.2c) . The luciferase activity of -204M1 and -204M2 were significantly higher than that of -204 (Fig.2b) , although the -204M1 luciferase mRNA expression was lower than that of -204 (Fig.2c) . These data suggested that disruption of the uORF by mutation of the start codon ATG at -105 increased the translation efficiency of the downstream ORF. Mutation of the ATG at -74 in construct -99M1 also significantly increased luciferase activity relative to -99, while again there was no difference in their respective mRNA expression levels (Fig.2c ). These data indicated that mutation of these uATGs in the 5'UTR was able to increase translation efficiency of the downstream ORF. To test this directly, in vitro translation assays were conducted for T7-5'UTR-luciferase constructs using the rabbit reticulocyte lysate system. Results from these in vitro translation assays were consistent with HepG2 cell data, with the exception that translation of the -204 construct was higher than the -247 construct in the in vitro translation assay (Fig.3b) . Mutation of the -74 ATG to AAG in -204M2 had no further stimulatory effect on translation efficiency than did mutation of the -105 ATG to AAG in 204 M1, indicating that in the longer transcripts, the -105 ATG is the primary constructs on downstream ORF translation (Fig. 4b) showed that there was no significant difference in inhibition of translation when the amino acid sequence was altered. These data indicated that inhibition of gene translation by the -105 uORF was not dependent on the amino acid sequence of the encoded peptide.
The inhibition of translation by the -105 uORF raised the question as to whether the uORF-encoded 22 amino acid peptide might inhibit translation as a cis-element or act as a trans-regulator where it could regulate translation of an independent gene. We mutated the uORF in construct -147 to create construct -147M2 in which the 22 amino acid peptide would not be translated (Fig.4c) . We also mutated the luciferase ORF in construct -147 to create a new construct, -147M3, in which the luciferase gene would not be translated (Fig. 4c) . The -147M3 and -147M2 constructs were mixed in equal amounts in in vitro translation assays. As a control, the -147M3 and C35 constructs were also mixed in equal amounts to test translation efficiency. The translation efficiency of the -147 construct was 57% of that of the C35 construct, while the translation efficiency of the -147M2 and C35 constructs were essentially equal, confirming the initial observation that disruption of the -105 uATG increased the translation efficiency 2-fold (p<0.0001). This also confirmed that the -105 uORF cis- HepG2 cells (Fig.5 a, 5b, 5c ). The same results were obtained in the in vitro translation assay of the -24C>T constructs, confirming that there was no difference in translational efficiency between the wild type and -24C>T mutant (Fig. 5d, 5e ).
This article has not been copyedited and formatted. The final version may differ from this version. mRNA is derepressed in amino acid-deprived cells; derepression is the orchestrated effect of four short uORFs (named uORF1-4) in GCN4 mRNA, together with the phosphorylation status of eukaryotic initiation factor 2 (eIF-2). In an amino acid-rich medium, ribosomes translate uORF1 and reinitiate primarily at uORF4, but are therefore unable to access the GCN4 ATG. In amino acid-deprived cells, ribosomes still translate uORF1, but bypass uORF2 -uORF4 and reinitiate at GCN4 ATG. In this case, uORF 4 and GCN4 ORF are competitors for the scanning ribosomes after translation of uORF1; the level of the active form of eIF2 determines whether uORF4 or GCN4 captures the ribosomes more efficiently. Clearly, much more work is needed to understand the factors that regulate MPR2 transcription, the use of MRP2 transcription start sites, and the translation start sites.
It is apparent that regulation of expression of functional MRP2 occurs at multiple levels and time frames: increased transcription and selection of transcription start site for long-term regulation, selection of translational start site for short-term regulation, and localization of MRP2 within the cell, either in the apical domain, or in endocytic vesicles (Mottino et al., 2002) , for immediate regulation. This array of regulatory mechanisms should thus allow the cell to respond to different stimuli and needs in various ways.
The MRP2 -24C>T variant occurs with a relatively high allelic frequency (18%) in Japanese subjects (Suzuki and Sugiyama, 2002) and is associated with changes in MRP2 expression, or drug-induced toxicity or pharmacokinetics. MRP2 -24C>T is associated with higher methotrexate plasma levels in female pediatric patients treated for acute lymphoblastic leukemia (Gradhand and Kim, 2008) , with increased susceptibility to toxic liver injury when a component of an MRP2 haplotype (Choi et al., 2007) , and with decreased MRP2 mRNA expression in non-cancerous kidney cortex (Haenisch et al., 2007) . While there has been some suggestion that the -24C>T SNP might affect the binding of transcription factors or RNA stability, we found no effect of this SNP on MRP2 mRNA expression or translational efficiency. In the present studies,
the -24C>T mutation was tested using MRP2 5'UTR fragment -99, which was inserted between the SV40 promoter and luciferase reporter. Since the transcription of the luciferase gene was driven by the SV40 promoter, the lack of effect on luciferase mRNA expression likely reflects the lack of effect of this mutation on mRNA stability. Clearly, the -24C>T mutation had no effect on the translational efficiency of the downstream ORF (Fig 5) . However, we cannot rule out a potential effect of the -24C>T mutation on differential transcriptional regulation of MRP2. 
